nivolumab,cabozantinib
bms
['nivolumab', 'nivo', 'sarcoma', 'cabozantinib']
significant activity of cabozantinib + nivolumab in taxane pretreated angiosarcoma. high orr in both cutaneous and non-cutaneous primaries. #sarcoma #asco23 
I treat patients with sarcoma and gastrointestinal malignancies at Hospital Israelita Albert Einstein, and serve as chair of  the LACOG sarcoma group